Nano Dimension Ltd. has sold its additively manufactured electronics (AME) product line and the previously discontinued Fabrica product line to Inspira Technologies OXY B.H.N. Ltd. The deal brings up to $12.5 million in consideration, consisting of a $2.0 million upfront cash payment and up to $10.5 million in deferred payments tied to the product lines’ performance over the next twelve months.
The transaction is expected to cut Nano’s annualized cash burn by roughly $10 million, improving liquidity and freeing management to concentrate on its core digital‑manufacturing platform and the integration of the Markforged acquisition. The sale is part of a broader strategic alternatives review that began in September 2025 and has already seen the company discontinue several non‑strategic assets.
"Today's announcement marks the first of a series of steps to maximize shareholder value and builds on the cost‑reduction actions initiated in the third quarter of 2025. The sale of the AME and Fabrica product lines will lower our operating costs and cash burn while reinforcing financial flexibility," said CEO David Stehlin.
Nano plans to update its 2026 financial guidance during its first‑quarter 2026 earnings call, reflecting the impact of the divestiture on its cash‑flow profile and margin outlook. The move aligns with the company’s goal of achieving profitability in 2026 and supports a leaner, higher‑margin business model.
The acquisition represents nearly 60% of Inspira Technologies’ current market capitalization, underscoring the strategic importance of the AME platform for the medical‑device company’s expansion beyond respiratory devices into advanced electronics manufacturing.
By shedding non‑core product lines, Nano Dimension is streamlining operations, reducing operating costs, and positioning itself to capitalize on high‑margin opportunities within its core platform and the Markforged integration. The sale is a key step in the company’s effort to strengthen its balance sheet and accelerate its path to profitability.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.